Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 8:28 pm Purchase | 13G | CELCUITY INC CELC | Venrock Healthcare Capital Partners III L.P. | 2,476,980 9.99% | 2,476,980 (New Position) | View |
| 2024-02-14 8:26 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Venrock Healthcare Capital Partners III L.P. | 15,564,213 7.5% | 9,664,724 (+163.82%) | View |
| 2024-02-14 8:26 pm Purchase | 13G | AMBRX BIOPHARMA INC AMAM | Venrock Healthcare Capital Partners III L.P. | 2,070,000 3.3% | 2,070,000 (New Position) | View |
| 2024-02-14 8:25 pm Purchase | 13G | ABIVAX SA SPONSORED ADS ABVX | Venrock Healthcare Capital Partners III L.P. | 3,611,570 5.7% | 298,570 (+9.01%) | View |
| 2024-02-01 4:15 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | Venrock Healthcare Capital Partners III L.P. | 4,428,385 6.6% | 4,428,385 (New Position) | View |
| 2024-01-02 4:16 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Venrock Healthcare Capital Partners III L.P. | 3,225,806 8.9% | 3,225,806 (New Position) | View |
| 2023-12-28 4:17 pm Purchase | 13G | OCULAR THERAPEUTIX INC OCUL | Venrock Healthcare Capital Partners III L.P. | 7,775,760 6.8% | 7,775,760 (New Position) | View |
| 2023-12-28 4:16 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Venrock Healthcare Capital Partners III L.P. | 3,573,714 10.3% | 657,047 (+22.53%) | View |
| 2023-11-30 4:15 pm Purchase | 13G | PHARVARIS N V REGISTERED PHVS | Venrock Healthcare Capital Partners III L.P. | 2,483,606 6.1% | 2,483,606 (New Position) | View |
| 2023-11-22 4:16 pm Purchase | 13G | ABIVAX SA SPONSORED ADS ABVX | Venrock Healthcare Capital Partners III L.P. | 3,313,000 5.3% | 3,313,000 (New Position) | View |
| 2023-09-29 4:15 pm Purchase | 13G | RAYZEBIO INC RYZB | Venrock Healthcare Capital Partners III L.P. | 4,016,847 6.6% | 4,016,847 (New Position) | View |
| 2023-09-21 4:15 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | Venrock Healthcare Capital Partners III L.P. | 927,706 6.3% | 927,706 (New Position) | View |
| 2023-08-28 4:16 pm Purchase | 13G | TAYSHA GENE THERAPIES INC TSHA | Venrock Healthcare Capital Partners III L.P. | 14,444,444 7.7% | 14,444,444 (New Position) | View |
| 2023-08-07 4:15 pm Purchase | 13G | MERSANA THERAPEUTICS INC MRSN | Venrock Healthcare Capital Partners III L.P. | 9,678,000 8.5% | 9,678,000 (New Position) | View |
| 2023-07-28 4:15 pm Purchase | 13D | APOGEE THERAPEUTICS INC APGE | Venrock Healthcare Capital Partners III L.P. | 3,887,478 9.99% | 3,887,478 (New Position) | View |
| 2023-07-24 4:16 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Venrock Healthcare Capital Partners III L.P. | 5,899,489 5.9% | 5,899,489 (New Position) | View |
| 2023-07-10 4:16 pm Purchase | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Venrock Healthcare Capital Partners III L.P. | 7,980,000 9.99% | 7,980,000 (New Position) | View |
| 2023-06-30 4:15 pm Purchase | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Venrock Healthcare Capital Partners III L.P. | 12,354,410 9.11% | 12,354,410 (New Position) | View |
| 2023-05-15 4:17 pm Purchase | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Venrock Healthcare Capital Partners III L.P. | 2,887,517 8.7% | 2,887,517 (New Position) | View |
| 2023-05-08 4:05 pm Purchase | 13G | APPLIED THERAPEUTICS INC APLT | Venrock Healthcare Capital Partners III L.P. | 5,797,585 9.99% | 5,797,585 (New Position) | View |